secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2024-08-20T23:59:59+00:00
Accession:  0001213900-24-070883
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics effects 1-for-15 reverse stock split to meet Nasdaq $1 minimum bid price
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-15 effective 12:01 a.m. ET on August 20, 2024; shares reduced from ~16 million to ~1.1 million.
- No fractional shares issued; holders of fractional shares receive cash based on 10-day average closing price before effective time.
- Split intended to bring common stock (CVKD) into compliance with Nasdaq's $1.00 minimum bid price requirement.
- New CUSIP number for common stock is 127636207; proportional adjustments made to outstanding equity awards and warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390024070883/0001213900-24-070883-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390024070883/ea021179601-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-070883

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer